Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 4
2004 2
2005 2
2006 5
2007 4
2008 8
2009 5
2010 13
2011 11
2012 18
2013 14
2014 8
2015 11
2016 8
2017 12
2018 17
2019 12
2020 9
2021 7
2022 9
2023 5
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

167 results

Results by year

Filters applied: . Clear all
Page 1
Prediction of future insulin-deficiency in glutamic acid decarboxylase autoantibody enzyme-linked immunosorbent assay-positive patients with slowly-progressive type 1 diabetes.
Kawasaki E, Awata T, Ikegami H, Imagawa A, Oikawa Y, Osawa H, Katsuki T, Kanatsuna N, Kawamura R, Kozawa J, Kodani N, Kobayashi T, Shimada A, Shimoda M, Takahashi K, Chujo D, Tsujimoto T, Tsuchiya K, Terakawa A, Terasaki J, Nagasawa K, Noso S, Fukui T, Horie I, Yasuda K, Yasuda H, Yanai H, Hanafusa T, Kajio H; Japanese Type 1 Diabetes Database Study (TIDE-J). Kawasaki E, et al. Among authors: imagawa a. J Diabetes Investig. 2024 Mar 7. doi: 10.1111/jdi.14178. Online ahead of print. J Diabetes Investig. 2024. PMID: 38451108 Free article.
Severe Drug-Induced Interstitial Lung Disease After Administration of Osimertinib as Adjuvant Treatment for Resected EGFR-Mutated NSCLC: A Case Report.
Mitsuya S, Arai M, Kanaoka K, Funamoto T, Tsuji H, Tsuruoka K, Matsunaga N, Nakamura T, Tamura Y, Imanishi M, Ikeda S, Imagawa A, Fujisaka Y. Mitsuya S, et al. Among authors: imagawa a. JTO Clin Res Rep. 2024 Jan 5;5(2):100631. doi: 10.1016/j.jtocrr.2024.100631. eCollection 2024 Feb. JTO Clin Res Rep. 2024. PMID: 38322711 Free PMC article.
New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes in Japan Diabetes Society (English version).
Shimada A, Kawasaki E, Abiru N, Awata T, Oikawa Y, Osawa H, Kajio H, Kozawa J, Takahashi K, Chujo D, Noso S, Fukui T, Miura J, Yasuda K, Yasuda H, Imagawa A, Ikegami H. Shimada A, et al. Among authors: imagawa a. Diabetol Int. 2024 Jan 8;15(1):1-4. doi: 10.1007/s13340-023-00679-1. eCollection 2024 Jan. Diabetol Int. 2024. PMID: 38264233
New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes of the Japan Diabetes Society (English version).
Shimada A, Kawasaki E, Abiru N, Awata T, Oikawa Y, Osawa H, Kajio H, Kozawa J, Takahashi K, Chujo D, Noso S, Fukui T, Miura J, Yasuda K, Yasuda H, Imagawa A, Ikegami H. Shimada A, et al. Among authors: imagawa a. J Diabetes Investig. 2024 Feb;15(2):254-257. doi: 10.1111/jdi.14121. Epub 2024 Jan 7. J Diabetes Investig. 2024. PMID: 38184802 Free PMC article.
Fulminant Type 1 Diabetes-East and West.
Imagawa A, Hanafusa T. Imagawa A, et al. J Clin Endocrinol Metab. 2023 Nov 17;108(12):e1473-e1478. doi: 10.1210/clinem/dgad329. J Clin Endocrinol Metab. 2023. PMID: 37309685
Bivalent GAD autoantibody ELISA improves clinical utility and risk prediction for adult autoimmune diabetes.
Kawasaki E, Shimada A, Imagawa A, Abiru N, Awata T, Oikawa Y, Osawa H, Kawabata Y, Kozawa J, Kobayashi T, Takahashi K, Chujo D, Fukui T, Miura J, Yasuda K, Yasuda H, Kajio H, Hanafusa T, Ikegami H; Committee of type 1 diabetes, Japan Diabetes Society. Kawasaki E, et al. Among authors: imagawa a. J Diabetes Investig. 2023 Apr;14(4):570-581. doi: 10.1111/jdi.13980. Epub 2023 Jan 23. J Diabetes Investig. 2023. PMID: 36691729 Free PMC article.
Inflammatory Cell Infiltration Into Islets Without PD-L1 Expression Is Associated With the Development of Immune Checkpoint Inhibitor-Related Type 1 Diabetes in Genetically Susceptible Patients.
Kawata S, Kozawa J, Yoneda S, Fujita Y, Kashiwagi-Takayama R, Kimura T, Hosokawa Y, Baden MY, Uno S, Uenaka R, Namai K, Koh Y, Tomimaru Y, Hirata H, Uemura M, Nojima S, Morii E, Eguchi H, Imagawa A, Shimomura I. Kawata S, et al. Among authors: imagawa a. Diabetes. 2023 Apr 1;72(4):511-519. doi: 10.2337/db22-0557. Diabetes. 2023. PMID: 36657987 Free PMC article.
167 results